secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cosmos Health Inc. (COSM)
CIK:        0001474167
Form:       8-K
Filed at:   2025-01-22T23:59:59+00:00
Accession:  0001477932-25-000373
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cosmos Health enters exclusive license for two cancer-treatment patents; up to EUR 7.5M buy-out
--------------------------------------------------------------------------------

- Exclusive worldwide license for two patents (filed 2016, 2017) to treat cancer; commercialize via R&D and trials.
- Initial payment $500K by Dec 31, 2024; fixed EUR 350K/year 2025-2030; thereafter 1.5% of Net Sales.
- Buy-out option to acquire patents for total EUR 7,500,000 (EUR 4M for Patent 1, EUR 3.5M for Patent 2).
- Licensor DocPharma is a related party; agreement governed by New York law; term for life of patents or 20 years.
- Cosmos has right to sublicense and terminate for convenience after 5 years; Licensor can terminate for uncured breach.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1474167/000147793225000373/0001477932-25-000373-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1474167/000147793225000373/cosm_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-25-000373

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer